...resistant Enterobacterales , Pseudomonas aeruginosa and Acinetobacter baumannii . REPAIR’s portfolio companies also include Curza, Entasis Therapeutics Inc....
...in May and is open to all companies worldwide. Inhua Muijrers-Chen, Associate Editor Novo Holdings A/S Spero Therapeutics Inc. Entasis Therapeutics Inc. Curza Procarta...

...Pseudomonas aeruginosa and Acinetobacter baumannii . REPAIR’s portfolio companies also include Curza [eds: full name], Entasis Therapeutics Inc....
...in May and is open to all companies worldwide. Inhua Muijrers-Chen, Associate Editor Novo Holdings A/S Spero Therapeutics Inc. Entasis Therapeutics Inc. Curza Procarta...

...Schindler was VP, clinical development and executive medical director at H3 Biomedicine Inc. Antibacterial company Entasis Therapeutics Inc....
...Inc. Genmab A/S Kintai Therapeutics Inc. Aerie Pharmaceuticals Inc. Oasmia Pharmaceutical AB Rafael Pharmaceuticals Inc. Arvelle Therapeutics GmbH Ovid Therapeutics Inc. Checkmate Pharmaceuticals Inc. Entasis Therapeutics Inc. Evaxion...

...Eric Kimble and Ruben Tommasi, chief commercial officer and CSO, respectively, of antibacterial therapy company Entasis Therapeutics Inc....

...Sutro Biopharma Inc. (NASDAQ:STRO). Matsui is a former EVP at Biogen Inc. (NASDAQ:BIIB). Antibiotic company Entasis Therapeutics...
...CFO of BioDelivery Sciences International Inc. (NASDAQ:BDSI). Mary Romeo, Staff Writer and Jonathan Block, Associate Editor Biogen Biogen Inc. Entasis Therapeutics Inc. Immunome...

...Knox as SVP, clinical development. Knox was VP, clinical research at Gilead Sciences Inc. (NASDAQ:GILD). Entasis Therapeutics...
...services for use in drug development and personalized cancer treatment decisions. BioCentury Staff Assembly Biosciences Inc. Caris Life Sciences Entasis Therapeutics Juvenescence...

...chemistry did not decrease avibactam’s activity. At least two companies are developing oral β-lactamase inhibitors. Entasis Therapeutics Inc.’s...
...Dublin, Ireland Arixa Pharmaceuticals Inc., Palo Alto, Calif. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Entasis Therapeutics Inc....

...Next steps could include testing the compound in animal models of additional Gram-positive bacterial infections. Entasis Therapeutics Inc....

...Novo Holdings A/S (Hellerup, Denmark) said its REPAIR Impact Fund invested in antibacterial companies Entasis Therapeutics Holdings...
...Makes First Investment in Swiss Antibiotic Company" ). Novo Holdings A/S, Hellerup, Denmark Business: Infectious Sandi Wong Entasis Therapeutics Inc. MinervaX...

...the $165 million antimicrobial resistance fund, which launched in February 2018, made 2018 investments in Entasis Therapeutics...